Today: 16 May 2026
Tesla stock today: TSLA edges higher after $41,990 Model Y AWD launch as Europe sales signals split
3 February 2026
1 min read

Tesla stock today: TSLA edges higher after $41,990 Model Y AWD launch as Europe sales signals split

NEW YORK, Feb 3, 2026, 10:47 AM EST — Regular session

  • Tesla shares gained roughly 0.5% during early trading
  • The company has introduced a new $41,990 all-wheel-drive Model Y variant in the U.S.
  • January European car registrations reveal uneven demand, marked by steep declines in Norway and France

Tesla (TSLA.O) shares climbed roughly 0.5% to $423.9 in early Tuesday trading following the launch of a new all-wheel-drive Model Y variant, priced at $41,990 in the U.S. The stock was last seen up $2.10 from Monday’s close.

The new trim shifts pricing back into focus for Tesla’s near-term outlook. Investors want to see if the company can hold onto volume in a cooling EV market without further margin erosion.

Demand signals from Europe remained patchy. January registrations, a sales proxy, surged 70% in Spain to 456 cars and rose 26% in Sweden to 512. Denmark saw a modest 3% increase to 458, while Italy jumped 75% to 713. But Norway’s registrations plunged 88% to 83, and France dropped 42% to 661. Portugal, Belgium, and the Netherlands also recorded declines. Tesla’s European market share shrank 27% last year, as Chinese competitor BYD ramped up pressure.

Italy’s transport ministry reported a 75% jump in Tesla registrations for January compared to last year, even as the automaker’s total sales in the country fell 18% in 2025. According to ministry data, Tesla registered 12,847 cars in 2025, down from 15,650 in 2024.

Tesla’s new Model Y update comes after it rolled out lower-priced “Standard” versions of its top sellers. Since the U.S. discontinued the $7,500 federal EV tax credit in September, the company has relied heavily on pricing adjustments and incentives, as that change bumped up the effective cost for many consumers.

But the trade-off is clear. Boosting low-priced vehicle sales can cut into profit per unit unless manufacturing costs drop or higher-margin software and services step in to compensate.

Investors are watching Elon Musk’s broader corporate empire closely. On Monday, Musk announced SpaceX’s acquisition of his AI startup xAI, sparking fresh concerns about governance and potential overlaps within his group, which includes Tesla. “Starlink was already a cash flow engine,” noted Ali Javaheri, senior emerging spaces analyst at PitchBook. Reuters

Macro factors are also at play. The U.S. Bureau of Labor Statistics announced the January employment report will be postponed due to a partial government shutdown. It had originally been set for release on Feb. 6 at 8:30 a.m. ET.

Risks remain two-sided for TSLA. Should price-driven demand falter or rivals tighten their grip in Europe, the recent rally in the stock might not hold up for long.

Traders are eyeing U.S. inflation next, with the January Consumer Price Index set for release on Feb. 11 at 8:30 a.m. ET. Attention will also focus on when the postponed jobs report will finally drop.

Stock Market Today

  • W. R. Berkley (WRB) Shows 45.9% Undervaluation Despite Recent Price Stability
    May 15, 2026, 7:55 PM EDT. W. R. Berkley (WRB) stock has shown limited movement recently with a 1.2% gain over 7 days and a 4.2% decline year-to-date. Analysts use valuation methods like Excess Returns, which estimates intrinsic value by calculating profits above shareholder required returns. With an intrinsic value estimate of $122.79 against a current price near $66.45, the stock appears 45.9% undervalued. The insurer's steady underwriting profile and capital discipline contrast with sector concerns on insurance pricing and interest rate sensitivity. WRB currently scores 2 out of 6 on valuation metrics, highlighting potential but raising caution.

Latest articles

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
SCHD dividend ETF is beating the S&P 500 in 2026 — what’s driving the comeback
Previous Story

SCHD dividend ETF is beating the S&P 500 in 2026 — what’s driving the comeback

5 IBM-Heavy ETFs to Watch as Mainframe Hits 20-Year High and the Stock Whipsaws
Next Story

5 IBM-Heavy ETFs to Watch as Mainframe Hits 20-Year High and the Stock Whipsaws

Go toTop